Aprogen Pharmaceuticals Inc (003060) — Cash Flow Reinvestment Rate
Aprogen Pharmaceuticals Inc (003060) has a Cash Flow Reinvestment Rate of 1.29x as of December 2022, reinvesting ₩870.30 Million (capex ₩591.03 Million plus investments ₩-279.27 Million) from operating cash flow of ₩676.93 Million. See how much free cash does Aprogen Pharmaceuticals Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Aprogen Pharmaceuticals Inc Cash Flow Reinvestment Rate (2010–2022)
Historical reinvestment intensity for Aprogen Pharmaceuticals Inc across 7 annual periods. For the full cash flow conversion analysis, see Aprogen Pharmaceuticals Inc (003060) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Aprogen Pharmaceuticals Inc (2010–2022)
Year-by-year capital reinvestment analysis for Aprogen Pharmaceuticals Inc. See 003060 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 2.12x | ₩54.55 Billion | ₩25.73 Billion | ₩1.55 Billion | ▼ -76.0% |
| 2020 | 8.84x | ₩71.48 Billion | ₩8.09 Billion | ₩976.29 Million | ▼ -85.4% |
| 2019 | 60.44x | ₩43.14 Billion | ₩713.73 Million | ₩2.13 Billion | ▲ +92.7% |
| 2018 | 31.37x | ₩41.77 Billion | ₩1.33 Billion | ₩1.01 Billion | ▼ -63.2% |
| 2016 | 85.22x | ₩38.35 Billion | ₩449.98 Million | ₩2.82 Billion | ▲ +733.9% |
| 2015 | 10.22x | ₩18.88 Billion | ₩1.85 Billion | ₩5.37 Billion | ▼ -79.4% |
| 2010 | 49.52x | ₩12.28 Billion | ₩247.92 Million | ₩12.28 Billion | — |